RAPT Therapeutics, Inc. (RAPT)

RAPT Therapeutics Statistics

Total Valuation

RAPT has a market cap or net worth of $799.46 million. The enterprise value is $644.71 million.

Market Cap	799.46M
Enterprise Value	644.71M

Important Dates

The last earnings date was Thursday, November 6, 2025, before market open.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

RAPT has 27.71 million shares outstanding. The number of shares has increased by 347.95% in one year.

Current Share Class	27.71M
Shares Outstanding	27.71M
Shares Change (YoY)	+347.95%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	0.30%
Owned by Institutions (%)	17.20%
Float	2.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.20
P/TBV Ratio	5.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.04, with a Debt / Equity ratio of 0.02.

Current Ratio	12.04
Quick Ratio	11.76
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -85.37% and return on invested capital (ROIC) is -55.17%.

Return on Equity (ROE)	-85.37%
Return on Assets (ROA)	-51.35%
Return on Invested Capital (ROIC)	-55.17%
Return on Capital Employed (ROCE)	-73.93%
Revenue Per Employee	n/a
Profits Per Employee	-$1.55M
Employee Count	68
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +129.70% in the last 52 weeks. The beta is 0.45, so RAPT's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	+129.70%
50-Day Moving Average	25.96
200-Day Moving Average	13.33
Relative Strength Index (RSI)	52.89
Average Volume (20 Days)	778,475

Short Selling Information

The latest short interest is 539,163, so 1.95% of the outstanding shares have been sold short.

Short Interest	539,163
Short Previous Month	500,148
Short % of Shares Out	1.95%
Short % of Float	25.89%
Short Ratio (days to cover)	1.72

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-112.64M
Pretax Income	-105.64M
Net Income	-105.64M
EBITDA	-111.66M
EBIT	-112.64M
Earnings Per Share (EPS)	-$4.88

Balance Sheet

The company has $157.34 million in cash and $2.60 million in debt, giving a net cash position of $154.75 million or $5.58 per share.

Cash & Cash Equivalents	157.34M
Total Debt	2.60M
Net Cash	154.75M
Net Cash Per Share	$5.58
Equity (Book Value)	151.98M
Book Value Per Share	9.02
Working Capital	147.67M

Cash Flow

In the last 12 months, operating cash flow was -$86.58 million and capital expenditures -$84,000, giving a free cash flow of -$86.66 million.

Operating Cash Flow	-86.58M
Capital Expenditures	-84,000
Free Cash Flow	-86.66M
FCF Per Share	-$3.13

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RAPT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-347.95%
Shareholder Yield	-347.95%
Earnings Yield	-13.21%
FCF Yield	-10.84%

Analyst Forecast

The average price target for RAPT is $57.00, which is 97.57% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$57.00
Price Target Difference	97.57%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-21.57%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 17, 2025. It was a reverse split with a ratio of 1:8.

Last Split Date	Jun 17, 2025
Split Type	Reverse
Split Ratio	1:8

Scores

Altman Z-Score	n/a
Piotroski F-Score	2